Concepedia

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

Paola Caroli, Israel Sandler, Federica Matteucci, Ugo De Giorgi, Licia Uccelli, Monica Celli, Flavia Foca, Domenico Barone, Antonino Romeo, Anna Sarnelli,

European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 92 citations · 39 references

DOIFull text

Open access

Concepts

References

39

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 3.2K citations · Full text

, , +6

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

Philip Cornford, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 1.4K citations

, , +7

Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

Stephen J. Freedland, Elizabeth B. Humphreys, Leslie A. Mangold et al. · JAMA · 2005 · 1.3K citations

Evaluation of Hybrid <sup>68</sup>Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

Matthias Eiber, Tobias Maurer, Michael Souvatzoglou et al. · Journal of Nuclear Medicine · 2015 · 984 citations

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 966 citations · Full text